MDMA · Pharmala Biotech Holdings Inc. · Financials
Market Cap
16.53M CAD
Shares
110.18M
Volume · Nov 6
62.49K
Avg daily vol (3M)
198.18K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
605.5K
-41.5%
FY2025
Net Income
-2.18M
-164.1%
FY2025
Gross Margin
91.22%
+5.5pp
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 |
|---|---|---|
| CAD | 605.5K | 1.04M |
| CAD | 552.34K | 887.44K |
| CAD | -2.18M | -823.6K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.